Plasma levels of interleukin-6 mediate neurocognitive performance in older breast cancer survivors: The Thinking and Living With Cancer study.
Jeanne S MandelblattBrent J SmallXingtao ZhouZev M NakamuraHarvey J CohenTim A AhlesJaeil AhnTraci N BetheaMartine ExtermannDeena GrahamClaudine IsaacsPaul B JacobsenHeather S L JimBrenna C McDonaldSunita J PatelKelly E RentscherJames C RootAndrew J SaykinDanielle B TometichKathleen M Van DykWanting ZhaiElizabeth C BreenJudith E CarrollPublished in: Cancer (2023)
Older breast cancer survivors had worse long-term neurocognitive performance than controls, and this relationship was explained in part by elevated IL-6.